Friday, January 28, 2022

New cancer drug to be made available on the NHS

It has been announced today that a ground-breaking cancer treatment will now be available on the NHS, reducing the risk of tumours returning and allowing patients to return to normal life.

  • The NHS has a strong track record of securing rapid access to innovative, trailblazing treatments for patients, but sadly lung cancer remains the most common cause of cancer death in the UK.
  • So it is fantastic news that a ground-breaking new drug, atezolizumab, which can significantly reduce the risk of cancer returning, is being made available allowing the NHS to offer thousands of lung cancer patients this new innovative treatment.
  • The agreement which has been signed to secure this drug will help NHS staff continue to deliver world-class patient care and save lives.